Your session is about to expire
← Back to Search
ABL301 for Healthy Subjects
Study Summary
This trial tests a new medicine for safety and how it affects the body. It's done in a safe and controlled way.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I weigh at least 50 kg and my BMI is between 19 and 30.I often have headaches, migraines, or I vomit more than twice a month.I have a history of heart problems, including high blood pressure or irregular heartbeat.I have not had any psychiatric disorders, suicidal thoughts in the last 6 months, or any suicide attempts.I have had cancer other than skin cancer in the last 5 years.I am a healthy adult between 18 and 55 years old.
- Group 1: Placebo
- Group 2: ABL301
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are elderly candidates excluded from participating in this research endeavor?
"Per the requirements for participation, participants must be between 18 to 55 years old."
Does this experiment require additional volunteers at the moment?
"Current information from clinicaltrials.gov reveals that this trial is accepting new participants, with the original posting date of December 31st 2022 and its most recent update being on March 6th 2023."
Is eligibility for participation in this trial open to me?
"To be eligible for this trial, candidates must be in good health and between 18 - 55 years of age. Approximately 40 participants are sought after."
How many participants are involved with this medical trial?
"Indeed, the details on clinicaltrials.gov demonstrate that this investigation is actively seeking out participants. This study was initially posted on December 31st 2022 and has been recently edited on March 6th 2023. 40 individuals are needed to be recruited across a single medical site."
Has the ABL301 drug been validated by the FDA?
"The safety of ABL301 is rated a 1, as the trial has only entered phase one which provides limited evidence for its efficacy and security."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger